Abstract
Melanoma is the most aggressive and dangerous type of skin cancer, but its molecular mechanisms remain largely unclear. For transcriptomic data of 478 primary and metastatic melanoma, nevi and normal skin samples, we performed high-throughput analysis of intracellular molecular networks including 592 signaling and metabolic pathways. We showed that at the molecular pathway level, the formation of nevi largely resembles transition from normal skin to primary melanoma. Using a combination of bioinformatic machine learning algorithms, we identified 44 characteristic signaling and metabolic pathways connected with the formation of nevi, development of primary melanoma, and its metastases. We created a model describing formation and progression of melanoma at the level of molecular pathway activation. We discovered six novel associations between activation of metabolic molecular pathways and progression of melanoma: for allopregnanolone biosynthesis, L-carnitine biosynthesis, zymosterol biosynthesis (inhibited in melanoma), fructose 2, 6-bisphosphate synthesis and dephosphorylation, resolvin D biosynthesis (activated in melanoma), D-myo-inositol hexakisphosphate biosynthesis (activated in primary, inhibited in metastatic melanoma). Finally, we discovered fourteen tightly coordinated functional clusters of molecular pathways. This study helps to decode molecular mechanisms underlying the development of melanoma.
Highlights
Melanoma is a type of skin cancer formed from melanocytes, skin cells that produce the pigment melanin
At the molecular pathway level, formation of nevi clearly resembles the transitional state from normal skin to primary melanoma
We provide evidence that at the molecular pathway level, nevi largely correspond to a transitional state from normal skin to primary melanoma
Summary
Melanoma is a type of skin cancer formed from melanocytes, skin cells that produce the pigment melanin. Treatment of primary melanoma includes surgical removal, and in the case of early diagnosis, the US survival rate reaches 91%. Melanomas are very active in forming metastases, and if not diagnosed at the early stage, the survival prognosis is poor [1]. Melanoma accounts for 75% of deaths related to skin cancer [1]. In 2012, melanoma occurred in 232,000 patients and resulted in 55,000 deaths worldwide [2]. About 40% of human melanomas contain activating mutations of the B-Raf protein, resulting in constitutive signaling through the Raf to MAP kinases growth signaling pathways [6]. The presence of multiple melanocytic nevi, a genetic trait compounded by sun exposure, increases the risk of developing melanoma, the transition from benign nevi to melanoma does not usually occur and what triggers this change is unknown
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.